8-K: Modular Medical Executes 1-for-30 Reverse Stock Split

Modular Medical, Inc. announced a 1-for-30 reverse stock split to maintain its Nasdaq listing, effective March 31, 2026.

Summary

• Modular Medical, Inc. (NASDAQ: MODD) filed a certificate of amendment to its amended and restated certificate of incorporation to effect a one (1)-for-thirty (30) reverse stock split of its common stock.
• The reverse stock split became effective at 5:30 a.m., Eastern Time, on March 31, 2026, with post-split trading commencing at market open on the same day under the new CUSIP number 60785L306.
• The primary purpose of the reverse stock split is to increase the per share trading price of the company's common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Stock Market LLC.
• The number of outstanding shares of common stock was reduced from 139,810,797 shares pre-split to approximately 4,660,360 shares post-split.
• The number of authorized shares of common stock and the par value per share ($0.001) will remain unchanged.
• All outstanding equity awards, common stock reserved for issuance under equity incentive plans, and warrants will be adjusted by dividing the number of affected shares by 30 and multiplying the exercise price by 30.
• No fractional shares will be issued; holders of fractional shares will receive cash in lieu thereof.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a necessary but generally negative corporate action, indicating past stock underperformance and potential underlying business challenges, despite addressing a critical listing requirement.

Positives

• The reverse stock split is intended to ensure continued compliance with Nasdaq's minimum bid price requirement, preventing potential delisting and maintaining access to a major exchange for liquidity and institutional investment.

Negatives

• A reverse stock split often signals a significant decline in the company's stock price, indicating underlying performance issues or market skepticism.
• The 1-for-30 ratio is substantial, reflecting a considerable need to boost the per-share price to meet listing requirements.

Risks

• The timing of the company's reverse stock split.
• Successful development of Modular Medical's proprietary technologies.
• Whether the market will accept Modular Medical's products and services.
• Anticipated consumer demand for the company's products.
• General economic, industry, or political conditions in the United States or internationally.
• The occurrence of future events or circumstances, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K.

Future Outlook

The company's forward-looking statements are subject to various risks and uncertainties, including the timing of the reverse stock split, successful development and market acceptance of its proprietary technologies, consumer demand, and general economic conditions. The company assumes no obligation to update these statements except as required by law.

Management Comments

• James E. Besser, Chief Executive Officer, signed the report on behalf of Modular Medical, Inc.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common defensive maneuver for development-stage medical device companies like Modular Medical that have experienced significant stock price depreciation, often due to prolonged periods without revenue generation or profitability. This action is critical for maintaining listing on major exchanges, which is vital for attracting capital and maintaining investor confidence, especially in a sector heavily reliant on funding for R&D and commercialization.

Comparison to Industry Standards

• Reverse splits are a standard strategy employed by companies across various industries, including biotech and medical devices, to regain compliance with exchange listing requirements. For instance, other development-stage companies such as Aytu BioPharma (AYTU) and Sio Gene Therapies (SIOX) have executed similar reverse splits to maintain Nasdaq compliance.
• The 1-for-30 ratio is a significant consolidation, indicating a substantial need to boost the per-share price, which is on the higher end compared to some other reverse splits that might be 1-for-5 or 1-for-10, suggesting a more pronounced challenge in maintaining share value.

Corporate Governance

Stakeholder Impact

• Shareholders will own fewer shares, but the per-share value will be proportionately higher, with no change to their overall equity value, except for fractional shares which will be cashed out.
• Proportionate voting rights and other rights of shareholders will not be affected by the reverse stock split.
• Maintaining Nasdaq listing benefits shareholders by preserving liquidity and visibility for the stock.

Next Steps

• Continued trading of common stock on the Nasdaq Capital Market on a split-adjusted basis.
• The company's transfer agent, Colonial Stock Transfer Co., Inc., will send instructions to shareholders of record regarding the exchange of certificates for uncertificated shares.

Key Dates

Recommendation

The reverse stock split is a critical action to maintain Nasdaq listing, which is positive for the company's market presence and access to capital. However, it does not address the underlying reasons for the low stock price. Investors should hold to monitor the company's operational progress and financial performance post-split, as the fundamental business outlook remains unchanged by this corporate action alone.

Keywords

Modular Medical, MODD, Reverse Stock Split, Nasdaq Listing, Corporate Action, Share Consolidation, Medical Device, Insulin Delivery